umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis
Show others and affiliations
2006 (English)In: National Academy of Sciences, USA: A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis, 2006, 14566-71 p.Conference paper, Published paper (Other academic)
Description
Abstract [en]

The intracellular pathogen Chlamydia trachomatis possesses a type III secretion (TTS) system believed to deliver a series of effector proteins into the inclusion membrane (Inc-proteins) as well as into the host cytosol with perceived consequences for the pathogenicity of this common venereal pathogen. Recently, small molecules were shown to block the TTS system of Yersinia pseudotuberculosis. Here, we show that one of these compounds, INP0400, inhibits intracellular replication and infectivity of C. trachomatis at micromolar concentrations resulting in small inclusion bodies frequently containing only one or a few reticulate bodies (RBs). INP0400, at high concentration, given at the time of infection, partially blocked entry of elementary bodies into host cells. Early treatment inhibited the localization of the mammalian protein 14-3-3beta to the inclusions, indicative of absence of the early induced TTS effector IncG from the inclusion membrane. Treatment with INP0400 during chlamydial mid-cycle prevented secretion of the TTS effector IncA and homotypic vesicular fusions mediated by this protein. INP0400 given during the late phase resulted in the detachment of RBs from the inclusion membrane concomitant with an inhibition of RB to elementary body conversion causing a marked decrease in infectivity.

Place, publisher, year, edition, pages
2006. 14566-71 p.
Keyword [en]
14-3-3 Proteins/metabolism, Anti-Bacterial Agents/chemistry/*pharmacology, Bacterial Proteins/*antagonists & inhibitors/metabolism, Cell Differentiation, Cell Membrane/metabolism, Chlamydia Infections/*drug therapy, Chlamydia trachomatis/cytology/*drug effects/*physiology/ultrastructure, Dose-Response Relationship; Drug, Inclusion Bodies/ultrastructure, Membrane Fusion, Phosphoproteins/metabolism, Protein Binding, Protein Transport
Identifiers
URN: urn:nbn:se:umu:diva-11787DOI: doi:10.1073/pnas.0606412103PubMedID: 16973741OAI: oai:DiVA.org:umu-11787DiVA: diva2:151458
Available from: 2007-06-12 Created: 2007-06-12 Last updated: 2017-05-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Bailey, LeslieSundin, CharlottaBergström, SvenElofsson, MikaelWolf-Watz, Hans
By organisation
Department of Chemistry

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 116 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf